Barbour 2019 race-free full IgAN model: 5-year risk of 50% eGFR decline or ESKD from age, eGFR, MAP, proteinuria g/day, Oxford MEST, RAS blockade, and immunosuppression at biopsy. Risk = 1 - S0(60)^exp(LP) with eTable 3 coefficients. Caller supplies eGFR; magent does not compute CKD-EPI or score the biopsy. Not the race/ethnicity model. Not KFRE. Not a diagnosis or treatment order. Not a medical device.

Payment Options